Paul Uhlman reports sale of 11,739 FHI shares
Paul Uhlman reports a sale of Class B Common stock of FHI totaling 11,739 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Paul Uhlman reports a sale of Class B Common stock of FHI totaling 11,739 shares.
The sale is dated 03/05/2026 with an aggregate amount of $663,595.10. The filing also lists multiple restricted stock vesting grants issued by the company with specific vesting dates and share counts.
Insights
Form 144 notifies the market of a reported insider disposition and lists related vested restricted stock events.
The filing shows a reported sale of 11,739 Class B Common shares by Paul Uhlman on 03/05/2026 for $663,595.10. This is a disclosure of a planned disposition under trading and reporting rules.
The excerpt also itemizes multiple restricted stock vesting events by the issuer with dates and share counts; these appear as compensation-related vestings, not additional open-market sales. Subsequent filings or trade reports may show execution details.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Paul Uhlman report in the FHI Form 144?
When was the reported transaction executed?
Does the filing show other equity events for FHI?
Who is the recipient of sale proceeds according to the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.